Theranostic application of telomerase-specific oncolytic adenovirus for human cancer

Toshiyoshi Fujiwara, Noriaki Tanaka

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Replication-selective tumor-specific viruses present a novel approach for treatment of neoplastic disease. Telomerase activation is considered to be a critical step in carcinogenesis and its activity correlates closely with human telomerase reverse transcriptase (hTERT) expression. We constructed an attenuated adenovirus 5 vector (Telomelysin, OBP-301), in which the hTERT promoter element drives expression of E1 genes. We further modified the E3 region of OBP-301 to contain green fluorescent protein (GFP) gene for monitoring viral replication (TelomeScan, OBP-401). When TelomeScan was intratumorally injected into human tumors orthotopically implanted into the rectum in mice, para-aortic lymph node metastasis could be visualized at laparotomy under a three-chip color cooled charged-coupled device camera. This article reviews recent highlights in this rapidly evolving field: cancer therapeutic and cancer diagnostic approaches using the telomerase-specific oncolytic adenoviruses.

Original languageEnglish
Pages (from-to)1913-1922
Number of pages10
JournalNippon rinsho. Japanese journal of clinical medicine
Volume65
Issue number10
Publication statusPublished - Oct 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Theranostic application of telomerase-specific oncolytic adenovirus for human cancer'. Together they form a unique fingerprint.

Cite this